Search alternatives:
significant increases » significant increase (Expand Search), significantly increased (Expand Search), significant decrease (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
increases costs » increased costs (Expand Search), increased post (Expand Search), increased across (Expand Search)
Showing 41 - 60 results of 35,850 for search '(( significant increases costs ) OR ( significant ((changes decrease) OR (largest decrease)) ))', query time: 0.69s Refine Results
  1. 41
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 42
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 43
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 44
    S1 Dataset -

    S1 Dataset - by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 45
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 46
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 47
    Pop-up for oral 3GC prescription.

    Pop-up for oral 3GC prescription. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 48
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 49
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 50
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 51
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 52
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 53
    Comparable characteristics between the two groups after PSM.

    Comparable characteristics between the two groups after PSM. by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 54
    Test of propensity score kernel density before propensity score matching.

    Test of propensity score kernel density before propensity score matching. by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 55
    Comparison of outpatient expenditure of the treatment and comparison groups before and after PSM (RMB).

    Comparison of outpatient expenditure of the treatment and comparison groups before and after PSM (RMB). by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 56
    Test of standardized percentage bias across covariates before and after propensity score matching.

    Test of standardized percentage bias across covariates before and after propensity score matching. by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 57
    Flow chart of the participants.

    Flow chart of the participants. by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 58
    Test of propensity score distribution before and after propensity score matching.

    Test of propensity score distribution before and after propensity score matching. by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 59
    Baseline characteristics of patients with hypertension (% 95%CI).

    Baseline characteristics of patients with hypertension (% 95%CI). by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 60
    Impact of the NEPHSP on the outpatient and inpatient expenditure after PSM.

    Impact of the NEPHSP on the outpatient and inpatient expenditure after PSM. by Long Xue (10926423)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: